Throughout his transformative career, David has led teams to develop and launch over 30 new medications worldwide. Currently, he serves as Chairman at Agomab, where he continues to drive strategic initiatives and support groundbreaking advancements in the field. Previously, he led Seagen through a period of marked growth and success as Chief Executive Officer—culminating in its merger with Pfizer.

If there's anyone who knows what it takes to rise through the ranks, push boundaries, motivate and inspire others, and enjoy a truly life-changing career, it's David. And you can learn from him by tuning in!